Cargando…

Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease

Anti-TNF biologics have been shown to markedly improve the quality of life for patients with Crohn’s disease (CD), yet one-third of patients fail to benefit from this treatment. Patients with CD develop a characteristic wrapping of visceral adipose tissue (VAT) in the inflamed intestinal area, terme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boronat-Toscano, Albert, Monfort-Ferré, Diandra, Menacho, Margarita, Caro, Aleidis, Bosch, Ramon, Espina, Beatriz, Algaba-Chueca, Francisco, Saera-Vila, Alfonso, Moliné, Alicia, Marti, Marc, Espin, Eloy, Millan, Mónica, Serena, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570367/ https://www.ncbi.nlm.nih.gov/pubmed/36232469 http://dx.doi.org/10.3390/ijms231911170

Ejemplares similares

Smoking Suppresses the Therapeutic Potential of Adipose Stem Cells in Crohn’s Disease Patients through Epigenetic Changes
por: Boronat-Toscano, Albert, et al.
Publicado: (2023)

The Gut Microbiota Metabolite Succinate Promotes Adipose Tissue Browning in Crohn’s Disease
por: Monfort-Ferré, Diandra, et al.
Publicado: (2022)

Microbial Signature in Adipose Tissue of Crohn’s Disease Patients
por: Serena, Carolina, et al.
Publicado: (2020)

Adipose stem cells from patients with Crohn’s disease show a distinctive DNA methylation pattern
por: Serena, Carolina, et al.
Publicado: (2020)

Crohn’s Disease Increases the Mesothelial Properties of Adipocyte Progenitors in the Creeping Fat
por: Madeira, Ana, et al.
Publicado: (2021)

Crohn's Disease Disturbs the Immune Properties of Human Adipose-Derived Stem Cells Related to Inflammasome Activation
por: Serena, Carolina, et al.
Publicado: (2017)

Anti-TNF Therapy in Crohn’s Disease
por: Adegbola, Samuel O., et al.
Publicado: (2018)

The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease
por: Iborra, Marisa, et al.
Publicado: (2022)

Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation
por: Sarrabayrouse, Guillaume, et al.
Publicado: (2020)

Randomised clinical trial to test the phenolization in sacrococcygeal pilonidal disease
por: Elvira Lopez, Jordi, et al.
Publicado: (2023)

Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients
por: Silva, Elen Farinelli de Campos, et al.
Publicado: (2018)

PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN’S DISEASE
por: dos SANTOS, Byanca Rossetti Moreira, et al.
Publicado: (2020)

TNF ( ΔARE ) Pigs: A Translational Crohn’s Disease Model
por: Winogrodzki, Thomas, et al.
Publicado: (2023)

The TNF-α -308 polymorphism may affect the severity of Crohn's disease
por: Santana, Genoile, et al.
Publicado: (2011)

Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2017)

Regulatory T cells in Crohn's disease following anti‐TNF‐α therapy
por: Chiba, Toshimi, et al.
Publicado: (2019)

Intestinal Tuberculosis Masquerading as Crohn's Disease? A Case of Disseminated Tuberculosis after Anti-TNF Therapy for Suspected Crohn's Disease
por: Abadir, Alexander P., et al.
Publicado: (2019)

Intestinal-Specific TNFα Overexpression Induces Crohn’s-Like Ileitis in Mice
por: Bamias, Giorgos, et al.
Publicado: (2013)

Disseminated Tuberculosis in a Patient Taking Anti-TNF Therapy for Crohn's Disease
por: Wang, Ming-Hsi, et al.
Publicado: (2015)

Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease
por: Lykowska-Szuber, Liliana, et al.
Publicado: (2021)

The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn’s disease activity
por: Eder, Piotr, et al.
Publicado: (2015)

Listeria Rhombencephalitis Complicating Anti-TNF Treatment during an Acute Flare of Crohn's Colitis
por: Stratton, L., et al.
Publicado: (2016)

Paradoxical SAPHO syndrome observed during anti-TNFα therapy for Crohn’s disease
por: Amano, Hitoshi, et al.
Publicado: (2017)

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
por: Chaparro, María, et al.
Publicado: (2019)

Anti-TNF Therapy Before Intestinal Surgery for Crohn’s Disease and the Risks of Postoperative Complications
por: Soop, Mattias, et al.
Publicado: (2021)

Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
por: Ye, Chenglin, et al.
Publicado: (2022)

TNFα Induces LGR5+ Stem Cell Dysfunction In Patients With Crohn’s Disease
por: Lee, Chansu, et al.
Publicado: (2021)

Molecular docking analysis of natural compounds as TNF-α inhibitors for Crohn's disease management
por: Moawadh, Mamdoh S
Publicado: (2023)

Case Report: Novel Homozygous Likely Pathogenic SCN1A Variant With Autosomal Recessive Inheritance and Review of the Literature
por: Marco Hernández, Ana Victoria, et al.
Publicado: (2021)

Management of complex perianal Crohn’s disease
por: Aguilera-Castro, Lara, et al.
Publicado: (2017)

Gestational diabetes impacts fetal precursor cell responses with potential consequences for offspring
por: Algaba‐Chueca, Francisco, et al.
Publicado: (2019)

Coexisting Crohn's Disease and Takayasu's Arteritis in Two Patients Treated with Anti-TNF-α Therapies
por: Ratuapli, S., et al.
Publicado: (2010)

Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease
por: Kamel, Amir Y., et al.
Publicado: (2016)

Leptin induces TNFα-dependent inflammation in acquired generalized lipodystrophy and combined Crohn’s disease
por: Ziegler, Jörn F., et al.
Publicado: (2019)

Evaluation of changes in intestinal microbiota in Crohn’s disease patients after anti-TNF alpha treatment
por: Sanchis-Artero, Laura, et al.
Publicado: (2021)

Identification of Targets for Subsequent Treatment of Crohn’s Disease Patients After Failure of Anti-TNF Therapy
por: Yao, Yao, et al.
Publicado: (2023)

Measuring patients’ satisfaction with their anti-TNF treatment in severe Crohn’s disease: scoring and psychometric validation of the Satisfaction for PAtients in Crohn’s diseasE Questionnaire (SPACE-Q(©))
por: Gilet, Hélène, et al.
Publicado: (2014)

Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease
por: Steenholdt, Casper, et al.
Publicado: (2016)

Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report
por: Bokemeyer, Arne, et al.
Publicado: (2018)

Mucosal IL13RA2 expression predicts nonresponse to anti‐TNF therapy in Crohn's disease
por: Verstockt, Bram, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2eda894vvs3o6ral4ia21hdrfg